Compare RPID & INTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RPID | INTT |
|---|---|---|
| Founded | 2006 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 204.3M | 175.3M |
| IPO Year | 2021 | 1997 |
| Metric | RPID | INTT |
|---|---|---|
| Price | $2.40 | $18.78 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $8.00 | ★ $13.50 |
| AVG Volume (30 Days) | 189.8K | ★ 254.0K |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 2.78 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $33,587,000.00 | ★ $66,801,000.00 |
| Revenue This Year | $19.12 | $15.82 |
| Revenue Next Year | $18.42 | $9.10 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 19.74 | ★ 66.06 |
| 52 Week Low | $2.01 | $5.56 |
| 52 Week High | $4.94 | $19.75 |
| Indicator | RPID | INTT |
|---|---|---|
| Relative Strength Index (RSI) | 47.98 | 66.08 |
| Support Level | $2.36 | $7.33 |
| Resistance Level | $2.46 | N/A |
| Average True Range (ATR) | 0.13 | 1.57 |
| MACD | 0.07 | 0.10 |
| Stochastic Oscillator | 77.53 | 79.17 |
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.
inTest Corp is a supplier of test and process technology solutions for use in manufacturing and testing across a wide range of markets, including Semi, Auto/EV, Defense/Aerospace, Industrial, Life Sciences, Safety/Security, and Other. The Company has three operating segments, which are also its reportable segments and reporting units: Electronic Test, which generates the majority of its revenue and includes semiconductor test equipment, flying probe, and in-circuit testers; Environmental Technologies, which includes thermal test, process, and storage products; and Process Technologies, which includes induction heating and video imaging products. The Company generates the maximum revenue from the U.S.